Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

IL-12 p40 prevents the development of chronic enterocolitis in IL-10-deficient mice.

Shiraki M, Aihara H, Kinouchi Y, Takahashi S, Oki M, Noguchi M, Takahashi K, Miyazaki J, Shimosegawa T.

Lab Invest. 2004 Nov;84(11):1491-500.

2.

Alloantigen-reactive Th1 development in IL-12-deficient mice.

Piccotti JR, Li K, Chan SY, Ferrante J, Magram J, Eichwald EJ, Bishop DK.

J Immunol. 1998 Feb 1;160(3):1132-8.

3.
4.

IL-12, but not IFN-gamma, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice.

Davidson NJ, Hudak SA, Lesley RE, Menon S, Leach MW, Rennick DM.

J Immunol. 1998 Sep 15;161(6):3143-9.

5.

Visualization of IL-12/23p40 in vivo reveals immunostimulatory dendritic cell migrants that promote Th1 differentiation.

Reinhardt RL, Hong S, Kang SJ, Wang ZE, Locksley RM.

J Immunol. 2006 Aug 1;177(3):1618-27.

6.

Toll-like receptor-dependent production of IL-12p40 causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice.

Kobayashi M, Kweon MN, Kuwata H, Schreiber RD, Kiyono H, Takeda K, Akira S.

J Clin Invest. 2003 May;111(9):1297-308.

7.

IL-23 provides a limited mechanism of resistance to acute toxoplasmosis in the absence of IL-12.

Lieberman LA, Cardillo F, Owyang AM, Rennick DM, Cua DJ, Kastelein RA, Hunter CA.

J Immunol. 2004 Aug 1;173(3):1887-93.

8.

Fenofibrate represses interleukin-17 and interferon-gamma expression and improves colitis in interleukin-10-deficient mice.

Lee JW, Bajwa PJ, Carson MJ, Jeske DR, Cong Y, Elson CO, Lytle C, Straus DS.

Gastroenterology. 2007 Jul;133(1):108-23. Epub 2007 Apr 11.

PMID:
17631136
9.

Both IL-12 and IL-18 contribute to small intestinal Th1-type immunopathology following oral infection with Toxoplasma gondii, but IL-12 is dominant over IL-18 in parasite control.

Vossenkämper A, Struck D, Alvarado-Esquivel C, Went T, Takeda K, Akira S, Pfeffer K, Alber G, Lochner M, Förster I, Liesenfeld O.

Eur J Immunol. 2004 Nov;34(11):3197-207.

10.

Evidence for the critical role of interleukin-12 but not interferon-gamma in the pathogenesis of experimental colitis in mice.

Tozawa K, Hanai H, Sugimoto K, Baba S, Sugimura H, Aoshi T, Uchijima M, Nagata T, Koide Y.

J Gastroenterol Hepatol. 2003 May;18(5):578-87.

PMID:
12702051
11.

Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12.

Becher B, Durell BG, Noelle RJ.

J Clin Invest. 2002 Aug;110(4):493-7.

12.

Mice deficient in Th1- and Th2-type cytokines develop distinct forms of hapten-induced colitis.

Dohi T, Fujihashi K, Kiyono H, Elson CO, McGhee JR.

Gastroenterology. 2000 Sep;119(3):724-33.

PMID:
10982767
13.

The prevention and treatment of murine colitis using gene therapy with adenoviral vectors encoding IL-10.

Lindsay JO, Ciesielski CJ, Scheinin T, Hodgson HJ, Brennan FM.

J Immunol. 2001 Jun 15;166(12):7625-33.

14.

Dynamics of gut mucosal and systemic Th1/Th2 cytokine responses in interferon-gamma and interleukin-12p40 knock out mice during primary and challenge Cryptosporidium parvum infection.

Tessema TS, Schwamb B, Lochner M, Förster I, Jakobi V, Petry F.

Immunobiology. 2009;214(6):454-66. doi: 10.1016/j.imbio.2008.11.015. Epub 2009 Jan 19.

PMID:
19155092
15.

A role for IL-27 in early regulation of Th1 differentiation.

Owaki T, Asakawa M, Morishima N, Hata K, Fukai F, Matsui M, Mizuguchi J, Yoshimoto T.

J Immunol. 2005 Aug 15;175(4):2191-200.

16.

IL-12p40 and IL-18 in crescentic glomerulonephritis: IL-12p40 is the key Th1-defining cytokine chain, whereas IL-18 promotes local inflammation and leukocyte recruitment.

Kitching AR, Turner AL, Wilson GR, Semple T, Odobasic D, Timoshanko JR, O'Sullivan KM, Tipping PG, Takeda K, Akira S, Holdsworth SR.

J Am Soc Nephrol. 2005 Jul;16(7):2023-33. Epub 2005 May 11.

17.

Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism.

Kullberg MC, Ward JM, Gorelick PL, Caspar P, Hieny S, Cheever A, Jankovic D, Sher A.

Infect Immun. 1998 Nov;66(11):5157-66.

18.

Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses.

Berg DJ, Davidson N, Kühn R, Müller W, Menon S, Holland G, Thompson-Snipes L, Leach MW, Rennick D.

J Clin Invest. 1996 Aug 15;98(4):1010-20.

19.

Production of biologically active equine interleukin 12 through expression of p35, p40 and single chain IL-12 in mammalian and baculovirus expression systems.

McMonagle EL, Taylor S, van Zuilekom H, Sanders L, Scholtes N, Keanie LJ, Hopkins CA, Logan NA, Bain D, Argyle DJ, Onions DE, Schijns VE, Nicolson L.

Equine Vet J. 2001 Nov;33(7):693-8.

PMID:
11770992
20.

Therapeutic effects of triptolide on interleukin-10 gene-deficient mice with colitis.

Wei X, Gong J, Zhu J, Niu L, Zhu W, Li N, Li J.

Int Immunopharmacol. 2008 Dec 20;8(13-14):1808-12. doi: 10.1016/j.intimp.2008.08.019. Epub 2008 Sep 17.

PMID:
18804190
Items per page

Supplemental Content

Write to the Help Desk